NB to develop a new skin metabolism model using iPSC derived skin cells

Working with academics Prof Mark Birch-Machin and Dr Peter Hanson from the Institute of Cellular Medicine, Newcells is using its expertise in cellular reprogramming and differentiation of iPSCs to provide cells that will be used to construct a new skin model that will enable understanding of skin metabolism of topical drugs and xenobiotics. The project titled Metaboderm was one of only three in the UK that received funding under the scheme and the project is sponsored by GSK, Unilever, Stiefel and Dstl.